Respiratory syncytial virus (RSV) is amongst the most important pathogenic infections of
childhood and is associated with significant morbidity and mortality. Although there have …

Background: There is growing recognition and understanding of the entities that cause
interstitial lung disease (ILD) in infants. These entities are distinct from those that cause ILD …

Guidance from the American Academy of Pediatrics (AAP) for the use of palivizumab
prophylaxis against respiratory syncytial virus (RSV) was first published in a policy statement …

Rationale: Respiratory syncytial virus (RSV) is the leading cause of acute lower respiratory
tract infections and hospitalizations in infants worldwide. Known risk factors, however …

BACKGROUND: Respiratory syncytial virus (RSV) infection is a leading cause of
hospitalization among infants. However, estimates of the RSV hospitalization burden have …

Although survival of individuals with cystic fibrosis (CF) has been continuously improving for
the past 40 years, respiratory failure secondary to recurrent pulmonary infections remains …

Importance Over the last 2 decades, bronchiolitis guidelines and improvement efforts
focused on supportive care and reducing unnecessary tests, treatments, and hospitalization …

Guidance from the American Academy of Pediatrics (AAP) for the use of palivizumab
prophylaxis against respiratory syncytial virus (RSV) was first published in a policy statement …

Abstract Introduction The REGAL (RSV Evidence–A Geographical Archive of the Literature)
series has provided a comprehensive review of the published evidence in the field of …

Over the last century, the primary burden of disease in children and young people has
shifted from infectious diseases towards chronic conditions. 1 Improvements in neonatal and …